Jeff Yass’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-323,783
| Closed | -$1M | – | 14669 |
|
|
2021
Q4 | $1M | Buy |
323,783
+244,207
| +307% | +$822K | ﹤0.01% | 7284 |
|
|
2021
Q3 | $287K | Sell |
79,576
-67,688
| -46% | -$255K | ﹤0.01% | 10704 |
|
|
2021
Q2 | $527K | Sell |
147,264
-31,389
| -18% | -$111K | ﹤0.01% | 9455 |
|
|
2021
Q1 | $699K | Buy |
178,653
+22,493
| +14% | +$92.9K | ﹤0.01% | 8656 |
|
|
2020
Q4 | $656K | Buy |
156,160
+94,871
| +155% | +$366K | ﹤0.01% | 7686 |
|
|
2020
Q3 | $229K | Sell |
61,289
-7,048
| -10% | -$30K | ﹤0.01% | 9247 |
|
|
2020
Q2 | $298K | Sell |
68,337
-27,864
| -29% | -$125K | ﹤0.01% | 8381 |
|
|
2020
Q1 | $365K | Buy |
96,201
+47,943
| +99% | +$236K | ﹤0.01% | 7601 |
|
|
2019
Q4 | $305K | Buy |
48,258
+10,916
| +29% | +$64.2K | ﹤0.01% | 7984 |
|
|
2019
Q3 | $157K | Sell |
37,342
-23,350
| -38% | -$99.7K | ﹤0.01% | 9298 |
|
|
2019
Q2 | $282K | Sell |
60,692
-479,274
| -89% | -$2.23M | ﹤0.01% | 8447 |
|
|
2019
Q1 | $2.86M | Buy |
539,966
+272,358
| +102% | +$1.24M | ﹤0.01% | 3196 |
|
|
2018
Q4 | $990K | Buy |
267,608
+249,728
| +1,397% | +$877K | ﹤0.01% | 4672 |
|
|
2018
Q3 | $50K | Buy |
+17,880
| New | +$50.2K | ﹤0.01% | 8852 |
|
|
2018
Q2 | – | Sell |
-34,199
| Closed | -$81.1K | – | 11034 |
|
|
2018
Q1 | $77K | Sell |
34,199
-85,206
| -71% | -$199K | ﹤0.01% | 8812 |
|
|
2017
Q4 | $352K | Sell |
119,405
-129,726
| -52% | -$359K | ﹤0.01% | 7317 |
|
|
2017
Q3 | $735K | Buy |
249,131
+50,388
| +25% | +$153K | ﹤0.01% | 5844 |
|
|
2017
Q2 | $556K | Buy |
198,743
+153,827
| +342% | +$325K | ﹤0.01% | 6449 |
|
|
2017
Q1 | $85K | Buy |
44,916
+20,257
| +82% | +$39.1K | ﹤0.01% | 8454 |
|
|
2016
Q4 | $43K | Buy |
+24,659
| New | +$50.4K | ﹤0.01% | 9326 |
|
|
2016
Q3 | – | Sell |
-128,156
| Closed | -$325K | – | 9683 |
|
|
2016
Q2 | $302K | Sell |
128,156
-184,715
| -59% | -$510K | ﹤0.01% | 6942 |
|
|
2016
Q1 | $1.01M | Sell |
312,871
-160,491
| -34% | -$593K | ﹤0.01% | 5061 |
|
|
2015
Q4 | $2.27M | Sell |
473,362
-348,435
| -42% | -$1.98M | ﹤0.01% | 3784 |
|
|
2015
Q3 | $4.57M | Buy |
821,797
+253,273
| +45% | +$1.87M | ﹤0.01% | 2799 |
|
|
2015
Q2 | $4.53M | Buy |
568,524
+279,524
| +97% | +$2.4M | ﹤0.01% | 3078 |
|
|
2015
Q1 | $3.04M | Buy |
289,000
+243,495
| +535% | +$3.33M | ﹤0.01% | 3543 |
|
|
2014
Q4 | $547K | Buy |
45,505
+4,821
| +12% | +$73.3K | ﹤0.01% | 7042 |
|
|
2014
Q3 | $695K | Sell |
40,684
-35,947
| -47% | -$522K | ﹤0.01% | 6616 |
|
|
2014
Q2 | $925K | Sell |
76,631
-41,936
| -35% | -$398K | ﹤0.01% | 6214 |
|
|
2014
Q1 | $1M | Buy |
118,567
+21,289
| +22% | +$172K | ﹤0.01% | 5529 |
|
|
2013
Q4 | $573K | Buy |
97,278
+69,700
| +253% | +$359K | ﹤0.01% | 6476 |
|
|
2013
Q3 | $150K | Buy |
+27,578
| New | +$133K | ﹤0.01% | 7919 |
|
Other funds holding BDSI
Jeff Yass's BDSI Position: Q1 2022 in Review
Jeff Yass sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 323,783 shares — an estimated $1M sold.
Jeff Yass first reported a position in BDSI in Q3 2013 and held it in 32 quarters. The position peaked at $4.57M in Q3 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Jeff Yass reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Jeff Yass sold 323,783 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1M.
- Jeff Yass first reported a position in BioDelivery Sciences International, Inc. in Q3 2013 and held it in 32 quarters.
- Jeff Yass's BioDelivery Sciences International, Inc. position peaked at $4.57M in Q3 2015.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.